24,25 Medication sensitivity also presents a common barrier to medications when they are tried, deterring both patients and clinicians from pursuing additional treatment

Disclosure of interest: Seyyed Sina Hejazian: nothing to disclose - Alireza Vafaei Sadr: nothing to disclose - Ajith Vemuri: nothing to disclose - Vida Abedi: nothing to disclose - Ramin Zand: nothing to disclose E-Posters - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.02 - LIFE AFTER STROKE P2228 - ESOC25-911 NEUROPSYCHIATRIC SEQUELAE AND COGNITIVE DEFICITS AFTER STROKE WITH THROMBECTOMY AND GOOD FUNCTIONAL OUTCOME (NESCAT): PRELIMARY RESULTS Naomi Giesers 1,2 , Constanze Buschmann 3 , Mandy Roheger 3 , Rachana Mahadevan 3 , Karsten Witt 1,2 , Thomas Liman 1,2,4 1 Neurology, Carl von Ossietzky-University Oldenburg, Oldenburg, Germany, 2 Evangelical Hospital Oldenburg, Oldenburg, Germany, 3 Department of Psychology, Carl von Ossietzky University Oldenburg, Oldenburg, Germany, 4 Charit, Berlin, Germany Background and Aims: Endovascular thrombectomy (EVT) significantly improves functional recovery following stroke, but cognitive deficits and neuropsychiatric sequelae in patients with favorable outcomes remain underexplored

Q4: Is 5-Amino-1MQ peptide intended for human or veterinary use
56% after 13 hr, n=62
Product Highlights Each vial contains 10 mL solution (~100 sprays) Each spray delivers 0.1 mL = 100 mcg BPC-157 Total BPC-157 Content: 10 mg per vial Specialized pharmaceutical-grade nasal solution designed for comfort and ease on the nose Unlike many other nasal sprays, this formula avoids irritation and dryness Packaged in Class A, lead-free pharmaceutical glass bottles Tamper/Child-Proof Cap + Orifice Reducer for integrity, sterility, and ease of use Description BPC-157 is explored for regenerative effects in connective tissues, muscle healing, gut protection, and vascular support